Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Proton Therapy Market – Insights
Proton therapy, also known as proton radiotherapy, uses high-energy beams to treat tumors. The approach involves depositing of a precision dose of high energy radiation in the target tumor. It is widely used in the treatment of cancer. Protons scatter less than other forms of x-ray radiation, thereby ensuring less damage to the surrounding healthy tissues.
The global proton therapy market is estimated to account for US$ 4,494.0 Mn in terms of value by the end of 2027.
Global Proton Therapy Market: Drivers
Increasing prevalence of cancer is expected to boost growth of the global proton therapy market over the forecast period. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018.
Moreover, increasing number of healthcare facilities offering proton therapy is also expected to aid in growth of the market. For instance, in February 2020, Illinois Health Facilities and Services Review Board approved the OSF HealthCare plan to construct cancer care center that offers proton-beam therapy.
Figure 1. Global Proton Therapy Market Share (%), by Region, 2019
Europe region held dominant position in the global proton therapy market in 2014, accounting for 37.2% share in terms of volume, followed by North America.
Source: Coherent Market Insights Analysis (2020)
Global Proton Therapy Market: Restraints
High cost of proton therapy is expected to hinder growth of the market. For instance, proton therapy costs range around US$ 30,000 to US$ 120,000.
Moreover, proton therapy devices are very larger in size and require a larger space with dedicated areas. The setup cost is exclusive of the device cost, which further increases investment, thereby limiting growth of the market.
Global Proton Therapy Market: Opportunities
Introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for players in the market. Currently, proton therapy is available in major developed countries such as Switzerland, Austria, U.S., China, Denmark, Japan, Netherlands, and Russia. Therefore, market players can focus on expanding their presence in emerging economies.
Moreover, development of compact machines is also expected to aid in growth of the market. Proton therapy devices currently available in the market require large area for set up. Therefore, market players can focus on reducing the size of all the parts in proton therapy devices.
Single Room segment in the global proton therapy market was valued at US$ 407.3 Mn in 2019 and is expected to reach US$ 980.0 Mn by 2027 at a CAGR of 11.6% during the forecast period.
Market Trends/Key Takeaways
Major players in the market are focused on expanding their presence in emerging economies. For instance, in February 2020, Ion Beam Applications S.A. signed a contract to install a ProteusONE compact proton therapy solution at the RSPAD Gatot Soebroto Presidential Hospital in Jakarta, Indonesia.
The market is witnessing increasing installation of standalone proton therapy centers. For instance, in March 2020, Stantec, a design and construction firm, delivered Johns Hopkins Hospital (U.S.) a new medical facility devoted specifically to proton therapy.
Global Proton Therapy Market: Competitive Landscape
Major players operating in the global proton therapy market include, Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, ProNova Solutions, LLC, ProTom International, Sumitomo Heavy Industries Ltd., and Varian Medical Systems.
Global Proton Therapy Market: Key Developments
Major players in the market are focused on expanding their customer base. For instance, in January 2020, Ion Beam Applications S.A. signed a contract with International Charity Foundation Cartu to install a ProteusONE solution in Georgia (U.S.)
Similarly, in November 2019, Mevion Medical Systems signed an agreement with Chung Shan Medical University Hospital and ASYS Corp to provide advanced proton therapy in Central Taiwan.